News Related to Pathological Complete Response

Related coverage linked through entity extraction aliases.

HFRT study identifies ISG15+MHC-I+ neutrophils in rectal cancer

Apr 05, 2026

A rectal cancer study found hypofractionated radiotherapy increased ISG15+MHC-I+ neutrophils with antigen-presenting capabilities. The report linked the effect to IFN-α/NOD1 signaling and improved anti-PD-1 responses in models.

Immunotherapy Expands Into Earlier Cancer Treatment Stages Across Multiple Tumor Types

Feb 13, 2026

Immunotherapy is increasingly being used before and after surgery across seven cancer types, while the global immunotherapy drugs market experiences significant growth driven by advances in biotechnology and targeted therapies.